Search results
GeoVax Reports First Quarter 2024 Financial Results and Provides Business Update
NewMediaWire via Yahoo Finance· 3 days agoPresented data on GEO-CM04S1 at World Vaccine Congress, delineating the unique immune system driven...
Protalix BioTherapeutics Inc (PLX) Q1 2024 Earnings Call Transcript Highlights: Navigating ...
GuruFocus.com via Yahoo Finance· 5 days agoThe intent is to position PRX-115 as a direct competitor in the market for uncontrolled gout patients. Q: How do the pharmacokinetic (PK) levels of PRX-115 trend over the observed three ...
Posts Claim Falsely That AstraZeneca Is Withdrawing Its COVID Vaccine Because of Blood Clots |...
The State· 2 days agoSince last week, hundreds of social media posts and news stories have claimed that AstraZeneca is removing its COVID vaccine from the market after admitting it caused blood clots in recipients ...
Pharma Stock Roundup: BAYRY's Q1 Earnings, JNJ's New Buyout, Pipeline Updates
Zacks· 24 hours agoBayer (BAYRY) releases Q1 results. J&J (JNJ) set to acquire private biotech, Proteologix, which will add atopic dermatitis candidates.
Does Medicare Cover the RSV Vaccine?
US News Health· 4 days agoCDC recommends vaccination for higher-risk populations. Two vaccines – Arexvy and Abrysvo – are currently approved by the FDA for those ages 60 and older and offers protection for two years.
GeoVax Reports First Quarter 2024 Financial Results and Provides Business Update
Digital Journal· 3 days agoPresented data on GEO-CM04S1 at World Vaccine Congress, delineating the unique immune system driven mechanisms that contribute to the broad efficacy of the vaccine candidate Significant milestone ...